Literature DB >> 26888478

The problem of representativeness of clinical trial participants: understanding the role of hidden costs.

Hala Borno1, Adam Siegel2, Charles Ryan3.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 26888478     DOI: 10.1177/1355819616630568

Source DB:  PubMed          Journal:  J Health Serv Res Policy        ISSN: 1355-8196


× No keyword cloud information.
  4 in total

1.  At What Cost to Clinical Trial Enrollment? A Retrospective Study of Patient Travel Burden in Cancer Clinical Trials.

Authors:  Hala T Borno; Li Zhang; Adam Siegel; Emily Chang; Charles J Ryan
Journal:  Oncologist       Date:  2018-04-26

2.  How current reporting practices may mask differences: A call for examining cancer-specific demographic enrollment patterns in cancer treatment clinical trials.

Authors:  Hala T Borno; Eric J Small; Li Zhang; Mindy C DeRouen; Ann Griffin; Joseph McGuire; Charles J Ryan; Robert A Hiatt; Celia P Kaplan
Journal:  Contemp Clin Trials Commun       Date:  2019-10-28

3.  Implementation of a Multisite Financial Reimbursement Program in Cancer Clinical Trials Integrated With Patient Navigation: A Pilot Randomized Clinical Trial.

Authors:  Hala T Borno; Li Zhang; Sylvia Zhang; Tracy K Lin; Andrea Skafel; Elena Nieves; Dana Dornsife; Robert Johnson; Kim Rhoads; Eric Small; Darcy Spicer
Journal:  JCO Oncol Pract       Date:  2022-02-23

4.  Prostate cancer patients' self-reported participation in research: an examination of racial/ethnic disparities.

Authors:  Nynikka R Palmer; Hala T Borno; Steven E Gregorich; Jennifer Livaudais-Toman; Celia P Kaplan
Journal:  Cancer Causes Control       Date:  2021-06-29       Impact factor: 2.532

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.